Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public markets pitfalls.

Today, our focus is on Valeo Pharma (VPH.C), a specialty pharmaceuticals firm bringing leading therapeutic products in the treatment of such conditions as asthma, Parkinson’s Disease and soft tissue Sarcoma to the Canadian market.

Enjoy!